Antidepressant Therapy: Choice Based on CYP2D6 Activity and Gender
Authors:
A. Žourková 1; E. Hadašová 2; L. Pulkrábková 1; M. Robeš 1; B. Ravčuková 3
Authors‘ workplace:
Psychiatrická klinika LF MU a FN, Brno
; přednostka prof. MUDr. E. Češková, CSc.
Farmakologický ústav LF MU, Brno
1; přednostka prof. MUDr. A. Šulcová, CSc.
Oddělení lékařské genetiky FN, Brno
2; přednostka prim. MUDr. R. Gaillyová
3
Published in:
Čes. a slov. Psychiat., 102, 2006, No. 4, pp. 183-188.
Category:
Original Article
Overview
The choice of a suitable antidepressant for maintenance therapy depends not only on the efficacy of the drug to be administered, but on its metabolization and the gender of the patient, his/her age and/or other medication, too. The goal of the study was to compare the therapeutic effect and incidence of sexual dysfunction in patients in paroxetine maintenance therapy treating a depressive and/or anxiety disorder with respect to gender and CYP2D6 activity. The findings support equal CYP2D6 activity in both genders and equal antidepressant effect disregarding the gender and CYP2D6 activity.
A unique finding of the study is varying incidence of sexual dysfunction depending on CYP2D6 activity within the group of female patients.
Key words:
antidepressants, CYP2D6, gender, efficacy, sexual dysfunction.
Labels
Addictology Paediatric psychiatry PsychiatryArticle was published in
Czech and Slovak Psychiatry
2006 Issue 4
Most read in this issue
- Velafaxine and Anxiety Disorders
- Sexual Abuse and Rape Experiences in Female Schizophrenic Patients
- Remission – a New Tool for Assessment of Treatment Efficacy
- Place and Value of Electroencephalography in Current Psychiatry